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background:  We examined the association of serum leptin with future cardiac structure and function.
Methods:  Multicenter longitudinal study of black, white, Hispanic and Asian men and women. 948 participants were included in this study. 
Cardiac MRI(CMR) was completed 6 years after serum leptin was measured. Leptin concentrations were log2 transformed to decrease 
skewness. Linear regression models adjusted for traditional risk factors(age, race, gender, systolic blood pressure, LDL, HDL, alcohol 
and tobacco use) were determined for CMR variables using log2 leptin(Model 1). Because leptin closely correlates with obesity, additional 
adjustment for BMI and diabetes was completed in a separate step(Model 2). Effect modification by BMI was examined by including 
interaction terms between log2 leptin and BMI. The analysis was repeated stratified by BMI(<25, 25-29.9, ≥30) for CMR variables with 
significant interactions.
Results:  Mean serum leptin was 19±22 ng/ml. A significant interaction term was present between BMI and leptin for the left ventricular(LV) 
mass model(p=0.003). In the LV mass model stratified by BMI(<25, 25-29.9 and ≥30), regression coefficients for log2 leptin were 
respectively -0.9±0.9g(p=0.30), -2±1g(p=0.02) and -0.7±1.3g(p=0.60).
conclusion:  Serum leptin was associated with less adverse future LV mass and volumes. BMI modified the association between leptin 
and future LV mass.
Table 1: Serum Log2 Leptin and Future Cardiac Structure: Beta coefficients±SE(p value) are noted.
CMR Variable Model 1 Model 2
LV Mass(g) 1.9±0.6(0.001) -2.1±0.7(0.002)
LV End Diastolic Volume(ml) 0.7±0.6(0.29) -2.4±0.8(0.002)
LV End Systolic Volume(ml) -0.1±0.4(0.87) -1.3±0.5(0.007)
LV Stroke Volume(ml) 0.7±0.4(0.06) -1.2±0.5(0.02)
LV Ejection Fraction(%) 0.2±0.2(0.29) 0.2±0.2(0.3)
